The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Integrated genomic and transcriptomic analysis to predict FOLFIRINOX response in metastatic pancreatic ductal adenocarcinoma.
 
Marjolein Francisca Lansbergen
No Relationships to Disclose
 
Mark Pui Gien Dings
No Relationships to Disclose
 
Jan Koster
Research Funding - Roche
 
Johanna Wilmink
Consulting or Advisory Role - AstraZeneca; MSD
Speakers' Bureau - MSD; SERVIER
Research Funding - MSD; Nordic Group; SERVIER
 
Hanneke W.M. Van Laarhoven
Consulting or Advisory Role - Amphera (Inst); Amphera (Inst); Anocca (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); BeiGene (Inst); Daiichi (Inst); Dragonfly Therapeutics (Inst); MSD Oncology (Inst); Servier
Speakers' Bureau - Astellas Pharma (Inst); BeiGene (Inst); BMS (Inst); Daiichy Sankyo (Inst); Novartis (Inst)
Research Funding - Auristone; Incyte (Inst); Merck KGaA (Inst); ORCA Therapeutics (Inst); Servier (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Maarten F. Bijlsma
Consulting or Advisory Role - Olympus; SERVIER; Wholomics
Research Funding - Celgene; Frame Therapeutics; Lead Pharma
Travel, Accommodations, Expenses - Wholomics
(OPTIONAL) Uncompensated Relationships - Wholomics